111 related articles for article (PubMed ID: 26753478)
21. [Correlations between hormone levels and psychiatric symptoms as well as cognitive function in drug-free first-episode schizophrenics].
Yuan XX; Zhu QY; Liang HB; Hei GR; Li X; Pang LJ; Li HH; Li H; Song XQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2155-60. PubMed ID: 27464540
[TBL] [Abstract][Full Text] [Related]
22. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
23. Hormonal reproductive status of women at menopausal transition compared to that observed in a group of midreproductive-aged women.
Sengos C; Iatrakis G; Andreakos C; Xygakis A; Papapetrou P
Clin Exp Obstet Gynecol; 2000; 27(1):54-6. PubMed ID: 10758802
[TBL] [Abstract][Full Text] [Related]
24. Hormones and menopausal status as predictors of depression in women in transition to menopause.
Freeman EW; Sammel MD; Liu L; Gracia CR; Nelson DB; Hollander L
Arch Gen Psychiatry; 2004 Jan; 61(1):62-70. PubMed ID: 14706945
[TBL] [Abstract][Full Text] [Related]
25. Effect of previous diagnoses of depression, menopause status, vasomotor symptoms, and neuroticism on depressive symptoms among climacteric women: A 30-month follow-up.
Chou CH; Ko HC; Wu JY; Chang FM; Tung YY
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):385-9. PubMed ID: 26384055
[TBL] [Abstract][Full Text] [Related]
26. Combined exercise training reduces climacteric symptoms without the additive effects of isoflavone supplementation: A clinical, controlled, randomised, double-blind study.
Costa JG; Giolo JS; Mariano IM; Batista JP; Ribeiro ALA; Souza TCF; de Oliveira EP; Resende APM; Puga GM
Nutr Health; 2017 Dec; 23(4):271-279. PubMed ID: 29214925
[TBL] [Abstract][Full Text] [Related]
27. 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.
Milewicz T; Krzysiek J; Sztefko K; Radowicki S; Krzyczkowska-Sendrakowska M
Endokrynol Pol; 2005; 56(6):876-82. PubMed ID: 16821205
[TBL] [Abstract][Full Text] [Related]
28. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis.
Straub RH; Zeuner M; Lock G; Schölmerich J; Lang B
Br J Rheumatol; 1997 Apr; 36(4):426-32. PubMed ID: 9159534
[TBL] [Abstract][Full Text] [Related]
29. The effect of physiological changes in ovarian steroids on the prolactin response to gonadotrophin releasing factor.
Tan YM; Steele PA; Judd SJ
Clin Endocrinol (Oxf); 1986 Jan; 24(1):71-8. PubMed ID: 3085991
[TBL] [Abstract][Full Text] [Related]
30. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.
Cohen LS; Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL
Am J Psychiatry; 2003 Aug; 160(8):1519-22. PubMed ID: 12900318
[TBL] [Abstract][Full Text] [Related]
31. Stable prolactin level after enhanced estradiol production following dehydroepiandrosterone sulfate.
Kauppila A; Ylikorkala O
Am J Obstet Gynecol; 1980 Oct; 138(3):271-2. PubMed ID: 6448002
[TBL] [Abstract][Full Text] [Related]
32. Effects of physical and depressive symptoms on the sexual life of Turkish women in the climacteric period.
Yanikkerem E; Göker A; Çakır Ö; Esmeray N
Climacteric; 2018 Apr; 21(2):160-166. PubMed ID: 29345506
[TBL] [Abstract][Full Text] [Related]
33. The assessment of the relationship between personality, the presence of the 5HTT and MAO-A polymorphisms, and the severity of climacteric and depressive symptoms in postmenopausal women.
Jurczak A; Szkup M; Wieder-Huszla S; Grzywacz A; Samochowiec A; Karakiewicz B; Samochowiec J; Grochans E
Arch Womens Ment Health; 2015 Aug; 18(4):613-21. PubMed ID: 25655492
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of TSH and prolactin responses to TRH as predictors of the therapeutic effect of ECT in depression.
Lykouras L; Markianos M; Augoustides A; Papakostas Y; Stefanis C
Eur Neuropsychopharmacol; 1993 Jun; 3(2):81-3. PubMed ID: 8364352
[TBL] [Abstract][Full Text] [Related]
35. Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women.
Lasco A; Cannavò S; Gaudio A; Morabito N; Basile G; Nicita-Mauro V; Frisina N
Eur J Endocrinol; 2002 Oct; 147(4):461-5. PubMed ID: 12370106
[TBL] [Abstract][Full Text] [Related]
36. Biopsychosocial risk factors of depression during menopause transition in southeast China.
Chu K; Shui J; Ma L; Huang Y; Wu F; Wei F; Meng X; Luo J; Ruan F; Zhou J
BMC Womens Health; 2022 Jul; 22(1):273. PubMed ID: 35790958
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors.
Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I
Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709
[TBL] [Abstract][Full Text] [Related]
38. The role of sex and sex-related hormones in cognition, mood and well-being in older men and women.
Castanho TC; Moreira PS; Portugal-Nunes C; Novais A; Costa PS; Palha JA; Sousa N; Santos NC
Biol Psychol; 2014 Dec; 103():158-66. PubMed ID: 25196100
[TBL] [Abstract][Full Text] [Related]
39. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
